These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3330337)

  • 1. Evaluation of ultrasonic attenuation in diffuse diseases of spleen and liver.
    Wilson LS; Robinson DE; Griffiths KA; Manoharan A; Doust BD
    Ultrason Imaging; 1987 Oct; 9(4):236-47. PubMed ID: 3330337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical sound speed measurement in liver and spleen in vivo.
    Chen CF; Robinson DE; Wilson LS; Griffiths KA; Manoharan A; Doust BD
    Ultrason Imaging; 1987 Oct; 9(4):221-35. PubMed ID: 3330336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency domain processing for ultrasonic attenuation measurement in liver.
    Wilson LS; Robinson DE; Doust BD
    Ultrason Imaging; 1984 Jul; 6(3):278-92. PubMed ID: 6396922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonic characterization of abdominal tissues via digital analysis of backscattered waveforms.
    Sommer FG; Joynt LF; Carroll BA; Macovski A
    Radiology; 1981 Dec; 141(3):811-7. PubMed ID: 7302239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of ultrasound in normal liver and diffuse liver disease in vivo.
    Maklad NF; Ophir J; Balsara V
    Ultrason Imaging; 1984 Apr; 6(2):117-25. PubMed ID: 6539974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver, gallbladder, and spleen.
    Carlsen EN
    Radiol Clin North Am; 1975 Dec; 13(3):543-56. PubMed ID: 1202578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonographic determination of the splenic size and its clinical usefulness in various liver diseases.
    Koga T; Morikawa Y
    Radiology; 1975 Apr; 115(1):157-61. PubMed ID: 1090976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo acoustic attenuation in liver: correlations with blood tests and histology.
    Duerinckx A; Rosenberg K; Hoefs J; Aufrichtig D; Cole-Beuglet C; Kanel G; Lottenberg S; Ferrari LA
    Ultrasound Med Biol; 1988; 14(5):405-13. PubMed ID: 3051614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenoportoscintigraphy to demonstrate portosystemic shunts.
    Höfer R; Ogris E; Pfeiffer G
    J Nucl Med; 1968 Dec; 9(12):624-9. PubMed ID: 5753338
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ultrasonic diagnosis of liver diseases].
    Minushkin ON; Boldyrev VV
    Ter Arkh; 1984; 56(8):120-2. PubMed ID: 6388004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver and spleen scintiscanning with indium 113m. A clinical pathologic correlation.
    Potchen EJ; Adatepe M
    Am J Roentgenol Radium Ther Nucl Med; 1969 Aug; 106(4):739-44. PubMed ID: 4308790
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on frequency-dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral-shift zero-crossing method.
    Itoh K; Yasuda Y; Suzuki O; Itoh H; Itoh T; Tsao JW; Konishi T; Koyano A
    J Clin Ultrasound; 1988 Oct; 16(8):553-62. PubMed ID: 3152399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrasonic tomography of the spleen--the clinical significance of the ultrasonic splotomogram in various liver diseases].
    Koga T; Higuchi N; Kinoshita T; Tomoe J
    Naika; 1970 Mar; 25(3):547-55. PubMed ID: 5444910
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear magnetic resonance of the liver, spleen, and pancreas.
    Stark DD; Moss AA; Goldberg HI
    Cardiovasc Intervent Radiol; 1986; 8(5-6):329-41. PubMed ID: 3009015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat.
    Taylor KJ; Riely CA; Hammers L; Flax S; Weltin G; Garcia-Tsao G; Conn HO; Kuc R; Barwick KW
    Radiology; 1986 Jul; 160(1):65-71. PubMed ID: 3520657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease?
    Sanford NL; Walsh P; Matis C; Baddeley H; Powell LW
    Gastroenterology; 1985 Jul; 89(1):186-91. PubMed ID: 3891495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic echography.
    Hébert G; Gélinas C
    Am J Roentgenol Radium Ther Nucl Med; 1975 Sep; 125(1):51-9. PubMed ID: 173198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative magnetic resonance methods for in vivo investigation of the human liver and spleen. Technical aspects and preliminary clinical results.
    Thomsen C
    Acta Radiol Suppl; 1996; 401():1-34. PubMed ID: 8604619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensitivity and specificity of 99mTc-sulfur colloid liver imaging in diffuse hepatocellular disease.
    Geslien GE; Pinsky SM; Poth RK; Johnson MC
    Radiology; 1976 Jan; 118(1):115-9. PubMed ID: 1244641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytology of infradiaphragmatic organs. 6. Liver.
    Wasastjerna C
    Monogr Clin Cytol; 1979; 7():167-93. PubMed ID: 379619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.